Editorial: can we afford the new direct-acting anti-virals for treatment of genotype 1 hepatitis C? Authors' reply

Aliment Pharmacol Ther. 2014 Oct;40(8):984-5. doi: 10.1111/apt.12939.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / economics*
  • Hepatitis C, Chronic / economics*
  • Humans
  • Interferon-alpha / economics*
  • Polyethylene Glycols / economics*
  • Ribavirin / economics*
  • Uridine Monophosphate / analogs & derivatives*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Polyethylene Glycols
  • Ribavirin
  • Uridine Monophosphate